Overview
Documents
Assay Highlights
The Novodiag® Bacterial GE+ assay, performed with the Novodiag System, is a cartridge-based molecular test for qualitative detection of bacterial gastroenteritis. The test uses stool samples from patients (without preservatives or in FecalSwabTM)*.
CE marked. Not for sale in the US.
*Copan Italia SpA
Documents
The Novodiag BGE+ assay enables fast on-demand diagnosis of bacterial gastroenteritis.
Smart simplicity in on-demand testing
Cartridge-based on-demand testing, that delivers clinical confidence in approximately an hour.
Features & Benefits
The Novodiag® assays allow a simple and fast way to pinpoint patients most at risk with targeted, multiplex and syndromic on-demand testing.
- Detects Yersinia virF gene and rumB marker and discriminates EHEC stx1 and stx2 toxins
- Clinical relevance: Identification of Yersinia species (Y. enterocolitica, Y. pestis, Y. pseudotuberculosis,) and Y. enterocolitica strains only if pathogenic, and stx2 associated with more severe diseases
- Faster diagnosis compared to traditional methods
- Time and cost effectiveness
- Improved patient outcome
-
Improved workflow and time to results
-
Increased lab revenue
- Better reproducibility, precision and productivity
- Time and labour saving
- No need for highly trained personnel enabling decentralised testing
Related Products
